动物提取物是指从不同种类的动物体内提取出的具有特定生物活性成分的物质。这些物质可以从动物的不同部分获取,包括血液、皮下脂肪、皮肤、骨骼、内脏器官等。
主要类别随着科学技术的发展,通过动物提取物获得生物活性物质的研究日益深入。这些研究不仅推动了新药的研发,也促进了相关产品的创新与发展。例如,从海洋动物中发现的海藻多糖类物质被认为具有良好的抗肿瘤、抗氧化等作用;而一些昆虫体内的抗菌肽也被广泛研究。
挑战与争议尽管动物提取物在多个领域展现出巨大潜力,但其使用也面临诸多挑战和争议:
综上所述,动物提取物作为生物资源的一种,在医药、化工等多个领域发挥着重要作用。随着科技的进步和社会价值观的变化,未来如何平衡其开发与利用之间的关系将是一个值得关注的问题。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
蟾蜍特尼定 | bufotenidine | 487-91-2 | C13H18N2O |
|
蜂毒素 | L-Leucinamide, L-isoleucyl-L-asparaginyl-L-leucyl-L-lysyl-L-alanyl-L-lysyl-L-alanyl-L-alanyl-L-leucyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl- | 145854-61-1 | C70H132N20O15 |
|
芋螺睡眠肽 | H-Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-OH | 133628-78-1 | C88H137N25O45 |
|
脂蟾毒精 | Resibufagin | 20987-24-0 | C24H30O5 |
|
缬氨酰-天冬氨酰-色氨酰-赖氨酰-赖氨酰-异亮氨酰-甘氨酰-谷氨酰胺酰-组氨酰-异亮氨酰-亮氨酰-丝氨酰-缬氨酰-亮氨酰胺 | Polistes mastoparan | 74129-19-4 | C77H127N21O18 |
|
磷脂酶A2来源于东部菱背响尾蛇毒液 | phospholipase A2 | 9001-84-7 | —— | —— |
海蟾蜍毒素 | marinobufagin | 470-42-8 | C24H32O5 |
|
氯毒素 | H-D-Met-D-Cys(1)-Met-Pro-D-Cys(2)-Phe-Thr-Thr-Asp-His-D-Gln-Met-Ala-Arg-Lys-DL-Cys(3)-Asp-Asp-Cys(1)-Cys(4)-Gly-Gly-D-Lys-Gly-D-Arg-Gly-D-Lys-D-Cys(2)-D-Tyr-Gly-Pro-D-Gln-DL-Cys(3)-D-Leu-Cys(4)-Arg-NH2 | 163515-35-3 | C158H249N53O47S11 |
|
地毯海葵毒素 | H-Arg-Ser-Cys(1)-Ile-Asp-aThr-Ile-Pro-Lys-Ser-Arg-Cys(2)-Thr-Ala-Phe-Gln-Cys(3)-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys(2)-D-Arg-D-Lys-aThr-Cys(3)-Gly-Thr-Cys(1)-OH | 172450-46-3 | C169H274N54O48S7 |
|
去乙酰华蟾毒精 | desacetylcinobufagin | 4026-95-3 | C24H32O5 |
|
MASTOPARANX肽 | Mastoparan X | 72093-22-2 | C73H126N20O15S |
|
MASTCELLDEGRANULATINGPEPTIDEHR-2肽 | Mast Cell Degranulating (MCD) Peptide HR-2 | 80388-04-1 | C77H135N17O14 |
|
MASTCELLDEGRANULATINGPEPTIDEHR-1肽 | Mast Cell Degranulating Peptide HR-1 | 80533-94-4 | C71H133N19O15 |
|
3,5-环核苷酸磷酸二酯酶(特异性) | 3',5'-cyclic-nucleotide phosphodiesterase | 9040-59-9 | —— | —— |
2-L-苯丙氨酸-4-L-精氨酸-8-L-精氨酸-缩宫素 | (Arg8)-Conopressin G trifluoroacetate | 130836-24-7 | C46H72F3N17O12S2 |
|
19-氧代华蟾毒它灵 | 19-oxocinobufotalin | 24512-60-5 | C26H32O8 |
|
—— | Marinobufagenin | 470-42-8 | C24H32O5 |
|
—— | (3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(1R,4S,7S,10S,13S,16S,19S,22S,25R,28S,31R,36R,39S,42S,45S)-31-amino-7,22-bis(4-aminobutyl)-39-benzyl-4-(2-carboxyethyl)-10,19-bis(carboxymethyl)-13-[(1R)-1-hydroxyethyl]-28-(hydroxymethyl)-42-[(4-hydroxyphenyl)methyl]-45-(2-methylpropyl)-16-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,38,41,44,47-tetradecaoxo-33,34,49,50-tetrathia-2,5,8,11,14,17,20,23,26,29,37,40,43,46-tetradecazabicyclo[23.22.4]henpentacontane-36-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | 120972-53-4 | C110H159N27O34S5 |
|
—— | 68-amino-36-(4-aminobutyl)-N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-22,51-bis(2-amino-2-oxoethyl)-33,60-bis(3-carbamimidamidopropyl)-8,47,78-trihydroxy-13,39-bis(1-hydroxyethyl)-4,16,57,74,86,89-hexakis(hydroxymethyl)-19,42-bis[(4-hydroxyphenyl)methyl]-2,5,11,14,17,20,23,32,35,38,41,44,50,53,56,59,62,69,72,75,81,84,87,90,97-pentacosaoxo-71-[4-[6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoylamino]butyl]-27,28,65,66,93,94-hexathia-3,6,12,15,18,21,24,31,34,37,40,43,49,52,55,58,61,70,73,76,82,85,88,91,96-pentacosazahexacyclo[52.37.4.225,63.06,10.045,49.076,80]heptanonacontane-30-carboxamide | 151928-23-3 | C136H207N41O46S7 |
|
—— | 5-((9S,17R)-3,14-Dihydroxy-10-hydroxymethyl-13-methyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-pyran-2-one | 39844-86-5 | C24H34O5 |
|
—— | 5-beta-BUFA-20,22-DIENOLIDE, 14,15-beta-EPOXY-3-beta,5,16-beta-TRIHYDROXY- | 4099-30-3 | C24H32O6 |
|
—— | Desacetylcinobufagin | 4026-95-3 | C24H32O5 |
|
—— | dehydrobufothionine | 475-39-8 | C12H14N2O4S |
|
—— | H-Ile-Asn-Trp-Lys-Gly-DL-Ile-Ala-Ala-Met-Ala-Lys-Lys-Leu-Leu-NH2 | 72093-22-2 | C73H126N20O15S |
|
—— | Mastoparan 7 | 145854-59-7 | C67H124N18O15 |
|
—— | Desacetylcinobufotalin | 4099-30-3 | C24H32O6 |
|
—— | Anthopleurin-A | 60880-63-9 | C215H326N62O67S6 |
|
—— | Sarafotoxin S6a | 126738-34-9 | C105H156N28O34S5 |
|
—— | 2-[(1R,4R,5aR,8aS,9R,12S,17aS,18S,20aS,21R,24S,27S,30S,33S,36S,39S,42S,45S,48S,51S,54R,59R,62S,65S,74S,77R,80S,86S,92S)-51,80,92-tris(4-aminobutyl)-5a-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]-9-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-39,62-bis(3-amino-3-oxopropyl)-24-benzyl-48,86-bis(3-carbamimidamidopropyl)-20a,33-bis(carboxymethyl)-27,30-bis[(1R)-1-hydroxyethyl]-74-[(4-hydroxyphenyl)methyl]-36-(1H-imidazol-4-ylmethyl)-45-methyl-8a-(2-methylpropyl)-12,42-bis(2-methylsulfanylethyl)-a,3,7a,10,10a,13,15a,18a,19,21a,22,25,28,31,34,37,40,43,46,49,52,61,64,70,73,76,79,82,85,88,91,94,97-tritriacontaoxo-2a,3a,6,7,12a,13a,56,57-octathia-2,6a,9a,11,14,16a,19a,20,22a,23,26,29,32,35,38,41,44,47,50,53,60,63,69,72,75,78,81,84,87,90,93,96,99-tritriacontazahexacyclo[57.41.10.84,54.421,77.014,18.065,69]docosahectan-17a-yl]acetic acid | 163515-35-3 | C158H249N53O47S11 |
|
—— | Deacetylcinobufagin | 4026-95-3 | C24H32O5 |
|